Innovative Clinical Trials: The LUNG-MAP Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Innovative Clinical Trials: The LUNG-MAP Study

Published:2015-04-20 Issue:5 Volume:97 Page:488-491
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Steuer CE¹,Papadimitrakopoulou V²,Herbst RS³,Redman MW⁴,Hirsch FR⁵,Mack PC⁶,Ramalingam SS¹,Gandara DR⁶

Affiliation:

1. Winship Cancer Institute; Emory University; Atlanta Georgia USA

2. University of Texas, MD Anderson Cancer Center; Houston Texas USA

3. Yale Comprehensive Cancer Center; Yale School of Medicine; New Haven Connecticut USA

4. Fred Hutchinson Cancer Research Center and Southwest Oncology Group Statistical Center

5. University of Colorado Cancer Center; Aurora Colorado USA

6. University of California Davis Cancer Center; Davis California USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference22 articles.

1. First-line crizotinib versus chemotherapy in ALK-positive lung cancer;Solomon;N. Engl. J. Med.,2014

2. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial;Rosell;Lancet Oncol.,2012

3. Cancer statistics, 2013;Siegel;CA Cancer J. Clin.,2013

4. Comprehensive genomic characterization of squamous cell lung cancers;Network CGAR;Nature,2012

5. New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response;Menis;Eur. Respir. Rev.,2014

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of an ISO 15189 accredited next generation sequencing service for cell-free total nucleic acid (cfTNA) analysis to facilitate driver mutation reporting in blood: the experience of a clinical diagnostic laboratory;Journal of Clinical Pathology;2024-06-24

2. Unlocking the Potential: A Systematic Review of Master Protocol in Pediatrics;Therapeutic Innovation & Regulatory Science;2024-04-23

3. Progress in genome-inspired treatment decisions for multifocal lung adenocarcinoma;Expert Review of Respiratory Medicine;2023-11-02

4. Precision Medicine in Respiratory Care: Where do We Stand Now?;Indian Journal of Respiratory Care;2023-10-30

5. Validation of Predictive Analyses for Interim Decisions in Clinical Trials;JCO Precision Oncology;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3